feed,title,long_url,short_url
SeekingAlpha,"Roche Q3 sales for Tecentriq +72%, Ocrevus +56% and Hemlibra +171% shoot up compensating COVID-19 impact and biosimilar erosion",https://seekingalpha.com/news/3622321,
SeekingAlpha,"Love The Greenbrier Companies, But Selling Into Strength",https://seekingalpha.com/article/4379168,
